Ross D. Hannan
305 Grattan Street
Melbourne, VIC 3000, Australia
Melbourne, VIC 3000, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 82 publications
Reply to: The chemotherapeutic drug CX-5461 is a potent mutagen in cultured human cells.
Journal: medRxiv : the preprint server for health sciences
Published: November 19, 2025
Renovating Neural Networks With Viral-Mediated Gene Transfer From A Tissue Contacting Matrix Mimic.
Journal: Small (Weinheim an der Bergstrasse, Germany)
Published: August 28, 2025
CX-5461 Preferentially Induces Top2α-Dependent DNA Breaks at Ribosomal DNA Loci.
Journal: Biomedicines
Published: May 30, 2024
Comprehensive translational profiling and STE AI uncover rapid control of protein biosynthesis during cell stress.
Journal: Nucleic acids research
Published: January 09, 2024
Targeting the ribosome to treat multiple myeloma.
Journal: Molecular therapy. Oncology
Published: November 30, 2023
Psi promotes Drosophila wing growth via direct transcriptional activation of cell cycle targets and repression of growth inhibitors.
Journal: Development (Cambridge, England)
Published: December 29, 2022
Cell death and barrier disruption by clinically used iodine concentrations.
Journal: Life science alliance
Published: December 13, 2022
Targeting mutant dicer tumorigenesis in pleuropulmonary blastoma via inhibition of RNA polymerase I.
Targeting mutant dicer tumorigenesis in pleuropulmonary blastoma via inhibition of RNA polymerase I.
Journal: Translational research : the journal of laboratory and clinical medicine
Published: September 17, 2022
Identification and characterization of a novel SNAT2 (SLC38A2) inhibitor reveals synergy with glucose transport inhibition in cancer cells.
Journal: Frontiers in pharmacology
Published: June 07, 2022
Last Updated: 09/26/2026